- 1 hr ago Rashmika Mandanna Is Grace Personified In A Saree, Check Out Latest Pictures!
- 6 hrs ago Retrograde Saturn Transit In Capricorn On 12 July 2022: Impact On Zodiac Signs And Remedies
- 6 hrs ago Daily Horoscope, 29 June 2022: Today's Horoscope Predictions For All Zodiac Signs
- 13 hrs ago Roe v. Wade Overturned: Why Is It Significant; Indian Laws On Abortion
- Technology Nokia G11 Plus With 50MP Dual Cameras, Unisoc T606 SoC Goes Official; India Launch Soon
- Movies Karan Malhotra Is Overwhelmed By Response To Shamshera Trailer; 'The Trailer Is Just The Tip Of The Iceberg'
- News Resorting to resorts: How resort politics has unfolded in India
- Automobiles Ather Energy May Soon Launch The Long-Range Version Of 450X Electric Scooter
- Finance Nifty Trading Lower By 0.55%, Sensex Falls By 0.59%: See 52-Week High Stocks
- Sports Thiago Silva urges 'super friend' Neymar to join him at Chelsea amid PSG exit talk
- Education PSEB 12th Result 2022 Declared At pseb.ac.in, Download Punjab Board Class 12 Result Here
- Travel Savandurga Hill In Monsoon - Hiking and Climbing
There is no clear evidence yet on the transmissibility, immune evasion or severity of Omicron in India, said Indian SARS-CoV-2 Genomics Consortium (INSACOG) in its latest bulletin while noting that the variant continues to grow rapidly as a variant of concern globally.
The bulletin, dated December 13 and published on Monday, said public health measures and investigations are being conducted to look into the new variant.
"At this time, there is no clear evidence regarding transmissibility, immune evasion, or severity in India," INSACOG said. It further said that while the Delta variant, including its B.1.617.2 (AY) and AY.x sublineages, continues to be the main variant of concern globally, Omicron continues to grow rapidly.
"Cases have continued to increase in South Africa, with a smaller but clear rise in hospitalizations. Pending complete genomic sequencing, in the UK, S-gene target failure has shown a very rapid increase in likely Omicron cases and this would represent a significant growth advantage against Delta," the INSACOG said.
The consortium said that while there are some indicators that the disease may be milder with Omicron, there is insufficient data to determine whether this is because of prior infections or vaccination.
"There is insufficient data for Omicron severity in unvaccinated or partially vaccinated older subjects," INSACOG said.
- wellnessIllnesses Caused By BA.2.38 Are Mild, Self-Limiting, Says Covid-19 Study
- wellnessGenome Sequencing Tests Show Omicron Dominating In Karnataka: Health Minister
- wellnessHow Does COVID Spread During Short Conversations?
- wellnessLong Covid-19 Risk Less With Omicron Than Delta Variant, UK Study Finds
- wellnessMore Contagious Subvariant Of Omicron Detected In Russia: What You Need To Know
- wellnessOmicron Subvariants BA.4 And BA.5 In India: What You Need To Know
- wellnessHaven't Had Covid-19 Yet? It Could Be More Than Just Luck
- wellnessSouth Africa In New Surge Of COVID-19 From Versions Of Omicron
- wellnessCovid-19 Cases May Rise In June-July, Speeding Up Vaccination Drive Best Way Ahead, Says Maharashtra Minister
- wellnessNew Plant-Based Covid Vaccine 70% Effective Against Variants: Study
- wellnessCovid Spread 1,000 Times More Likely From Air Than Surfaces: Study
- wellnessDelta Or Different Variant May Cause Another Covid Outbreak: Study